148 related articles for article (PubMed ID: 4193195)
1. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
2. The interaction between LATS and thyroid tissue in vitro.
Smith BR; Munro DS
Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011
[No Abstract] [Full Text] [Related]
3. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
4. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
[No Abstract] [Full Text] [Related]
5. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
6. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
7. The interaction between thyroid tissue and the long-acting thyroid stimulator.
Kendall-Taylor P; Smith BR; Munro DS
Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
[No Abstract] [Full Text] [Related]
8. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
9. Neonatal transient thyrotoxicosis resulting from maternal TSH-binding inhibitor immunoglobulins.
Yagi H; Takeuchi M; Nagashima K; Suzuki S; Kuroume T; Iida Y; Konishi J; Endo K
J Pediatr; 1983 Oct; 103(4):591-3. PubMed ID: 6137525
[No Abstract] [Full Text] [Related]
10. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
[No Abstract] [Full Text] [Related]
11. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
Wong ET; Litman GW
J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
[No Abstract] [Full Text] [Related]
12. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
13. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
Beall GN; Chopra IJ; Solomon DH
Clin Exp Immunol; 1971 Apr; 8(4):647-56. PubMed ID: 5576294
[TBL] [Abstract][Full Text] [Related]
14. Antibody nature of the long-acting thyroid stimulator.
Földes J; Takõ J; Bãnos C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(3):313-9. PubMed ID: 5154552
[No Abstract] [Full Text] [Related]
15. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
Lepp A; Oliner L
Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
[No Abstract] [Full Text] [Related]
16. Discrepancy between inactivation by thyroid particulate fraction and thyroid stimulating activity of long-acting thyroid stimulator (LATS).
Shishiba Y; Shimizu T; Yoshimura S; Shizume K
J Clin Endocrinol Metab; 1972 Jan; 34(1):7-12. PubMed ID: 5061777
[No Abstract] [Full Text] [Related]
17. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
Orgiazzi J; Pousset G; Durand H
Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
[No Abstract] [Full Text] [Related]
18. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
[No Abstract] [Full Text] [Related]
19. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.
Mori T; Kriss JP
J Clin Endocrinol Metab; 1971 Oct; 33(4):688-98. PubMed ID: 5109861
[No Abstract] [Full Text] [Related]
20. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
